- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06224504
Clinical Effectiveness of Combining Mindfulness-Based Stress Reduction With Exercise Interventione
January 16, 2024 updated by: Wanling Li, Shanxi Bethune Hospital
Combined Mindfulness-Based Stress Reduction and Exercise Intervention for Improving Psychological Well-being in Chinese Patients With Non-Small Cell Lung Cancer
This study is to assess the clinical effectiveness of combining Mindfulness-Based Stress Reduction (MBSR) with exercise intervention in improving anxiety, depression, sleep quality, and mood regulation in Chinese patients with non-small cell lung cancer (NSCLC).The control group received conventional psychological nursing care, while the intervention group received a combination of MBSR and exercise therapy.
Pre- and post-treatment scores of anxiety, depression, sleep quality, and the BSRS-5 were compared.
Study Overview
Status
Completed
Conditions
Detailed Description
To assess the clinical effectiveness of combining Mindfulness-Based Stress Reduction (MBSR) with exercise intervention in improving anxiety, depression, sleep quality, and mood regulation in Chinese patients with non-small cell lung cancer (NSCLC).
A total of 60 lung cancer patients from a hospital in Shanxi Province were selected using convenience sampling and divided into an intervention group and a control group, with 30 patients in each group.
The control group received conventional psychological nursing care, while the intervention group received a combination of MBSR and exercise therapy.
The two group were evaluated by the questionnaire three times.
One day before the intervention, the first questionnaire was conducted, and the basic data of the two groups of patients were collected.
The second questionnaire evaluation of anxiety, depression, sleep quality, and the Brief Symptom Rating Scale (BSRS-5) was conducted 6 weeks after the end of the intervention, and the third questionnaire evaluation was conducted 8 weeks after the end of the intervention to evaluate the intervention effect of the two groups.
Pre- and post-treatment scores of anxiety, depression, sleep quality, and the BSRS-5 were compared.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanxi
-
Taiyuan, Shanxi, China, 030032
- Combined Mindfulness-Based Stress Reduction and Exercise Intervention for Improving Psychological Well-being in Chinese Patients with Non-Small Cell Lung Cancer
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- patients diagnosed with non-small cell lung cancer
- patients aged between 20 and 74 years, without gender limitation
- a score of 4-14 on the Short Symptom Rating Scale (BSRS-5)
- a clinical prognosis of at least 6 months
- clear consciousness, good functional ability, and unrestricted language communication
- written informed consent provided by the patient
Exclusion Criteria:
- patients with severe physical illnesses or symptoms that impede learning and are considered life-threatening
- patients with a BSRS-5 assessment score > 15 and suicidal ideation > 2
- patients unable to accurately describe their symptoms
- patients with limited cooperation ability
- patients who have previously undergone MBSR or other positive-thinking-focused psychotherapy methods
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: the intervention group
routine health education , psychological nursing, MBSR therapy , exercise therapy
|
guided the diet of patients, and introduced the knowledge of the disease in detail
hen the patient has negative emotions, patiently listen to the patient's expression, and timely provide language comfort and guidance to the negative psychological emotions
Conducted in small groups once a week for 8 weeks, with each session lasting approximately 1-1.5 hours, encompassed mindfulness-based breathing exercises, dietary interventions, and body scans
Participants were assigned daily tasks for each session, requiring approximately 35-45 minutes per day
|
Active Comparator: the control group
routine health education , psychological nursing
|
guided the diet of patients, and introduced the knowledge of the disease in detail
hen the patient has negative emotions, patiently listen to the patient's expression, and timely provide language comfort and guidance to the negative psychological emotions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SAS score
Time Frame: one day before the intervention
|
Self-Rating Anxiety Scale (SAS)
|
one day before the intervention
|
SAS score
Time Frame: at 6 weeks after the intervention
|
Self-Rating Anxiety Scale (SAS)
|
at 6 weeks after the intervention
|
SAS score
Time Frame: at 8 weeks after the intervention
|
Self-Rating Anxiety Scale (SAS)
|
at 8 weeks after the intervention
|
SDS score
Time Frame: one day before the intervention
|
Self-Rating Depression Scale (SDS)
|
one day before the intervention
|
SDS score
Time Frame: at 6 weeks after the intervention
|
Self-Rating Depression Scale (SDS)
|
at 6 weeks after the intervention
|
SDS score
Time Frame: at 8 weeks after the intervention
|
Self-Rating Depression Scale (SDS)
|
at 8 weeks after the intervention
|
BSRS-5 score
Time Frame: one day before the intervention
|
the five-item Brief Symptom Rating Scale (BSRS-5)
|
one day before the intervention
|
BSRS-5 score
Time Frame: at 6 weeks after the intervention
|
the five-item Brief Symptom Rating Scale (BSRS-5)
|
at 6 weeks after the intervention
|
BSRS-5 score
Time Frame: at 8 weeks after the intervention
|
the five-item Brief Symptom Rating Scale (BSRS-5)
|
at 8 weeks after the intervention
|
PSQI score
Time Frame: one day before the intervention
|
Pittsburgh Sleep Quality Index (PSQI)
|
one day before the intervention
|
PSQI score
Time Frame: at 6 weeks after the intervention
|
Pittsburgh Sleep Quality Index (PSQI)
|
at 6 weeks after the intervention
|
PSQI score
Time Frame: at 8 weeks after the intervention
|
Pittsburgh Sleep Quality Index (PSQI)
|
at 8 weeks after the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Wanling Li, Shanxi Bethune Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2021
Primary Completion (Actual)
January 1, 2022
Study Completion (Actual)
January 1, 2024
Study Registration Dates
First Submitted
January 16, 2024
First Submitted That Met QC Criteria
January 16, 2024
First Posted (Estimated)
January 25, 2024
Study Record Updates
Last Update Posted (Estimated)
January 25, 2024
Last Update Submitted That Met QC Criteria
January 16, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SBH-001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Non-Small Cell Lung Cancer
-
WindMIL TherapeuticsBristol-Myers SquibbTerminatedNSCLC | Lung Cancer | Lung Cancer Metastatic | Lung Cancer, Non-small Cell | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer MetastaticUnited States
-
University of California, San FranciscoAstraZenecaActive, not recruitingStage IIIA Non-Small Cell Lung Cancer | Stage I Non-Small Cell Lung Cancer | Stage IA Non-Small Cell Lung Cancer | Stage IB Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Cancer | Stage IIB Non-Small Cell Lung CancerUnited States
-
AIO-Studien-gGmbHBristol-Myers Squibb; Eli Lilly and Company; Merck Sharp & Dohme LLC; Pfizer; Gilead... and other collaboratorsRecruitingSmall-cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage I | Metastatic Non-small Cell Lung Cancer (NSCLC) | Non Small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer Stage IIGermany
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Healthy, no Evidence of Disease | Limited Stage Small Cell Lung... and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-small Cell Lung Cancer | Stage IA Non-small Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerUnited States
-
Alexander ChiNot yet recruitingNon-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | Non-small Cell Carcinoma | Non-small Cell Lung Cancer Stage IIChina
-
National Cancer Institute (NCI)Not yet recruitingStage IIIA Non-small Cell Lung Cancer | Stage IA Non-small Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerCanada
-
Stanford UniversityAstraZenecaRecruitingNon-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIUnited States
-
Karen KellyBristol-Myers Squibb; National Cancer Institute (NCI); TransgeneCompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Stage I Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung CancerUnited States
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung CancerUnited States
Clinical Trials on routine health education
-
Junyan ZhaoActive, not recruitingTumor Chemotherapy PatientsChina
-
Tianjin HospitalCompletedLumbar Disc HerniationChina
-
Li-Li ChenUnknownType 2 Diabetes MellitusTaiwan
-
Sokoine University of AgricultureNestlé Foundation; Institute of Tropical Medicine, Belgium; University Ghent; Nutrition... and other collaboratorsUnknownMalnutrition | Growth RetardationTanzania
-
Chang Gung Memorial HospitalCompletedChronic Kidney Diseases | Acute Kidney Injury | Acute on Chronic Renal FailureTaiwan
-
Chung Shan Medical University HospitalRecruitingParental Anxiety | Congenital Heart Disease in Children | Catheterization | Educational Videos | Parental UncertaintyTaiwan
-
Chung Shan Medical UniversityCompletedDepression | COVID-19 | Anxiety | Children | Congenital Heart Disease | Uncertainty | Maternal | Educational VideosTaiwan
-
Chung Shan Medical University HospitalCompletedSurgery | Congenital Heart Disease in Children | Maternal Depression | Educational Videos | Maternal AnxietyTaiwan
-
Junyan ZhaoActive, not recruitingStomach Cancer | Breast Cancer | Lung Cancer | Rectal Cancer | Colon Cancer | Liver CancerChina
-
Zunyi Medical CollegeCompleted